Rnf25-flox Mouse

Rnf25, also known as AO7, is an E3 ubiquitin ligase that plays diverse roles in multiple biological processes and disease-related pathways. It is involved in pathways such as Wnt signaling, ribosome-associated quality control, and is relevant in diseases like cancer and potentially Parkinson's disease. Genetic models, including gene knockout and conditional knockout mouse models, could be valuable in further elucidating its functions [4,2,7,6].

In cancer, loss-of-function studies have shown significant implications. Repression of Rnf25 induces E-cadherin protein expression and inhibits hepatocellular carcinoma (HCC) metastasis, indicating its role in promoting HCC metastasis through E-cadherin degradation [1]. In EGFR-mutant non-small cell lung cancer (NSCLC) cells, depletion of Rnf25 sensitizes cells to gefitinib treatment, suggesting it is essential for gefitinib resistance by mediating cross-talk between NF-κB and ERK pathways [3]. In colorectal cancer liver metastasis, circSATB1 promotes FKBP8 degradation via RNF25-mediated ubiquitination, enhancing metastatic ability [5].

In conclusion, Rnf25 is a key E3 ubiquitin ligase with essential functions in multiple biological processes, especially in cancer-related pathways. Model-based research, particularly gene knockout studies in relevant cancer models, has revealed its importance in promoting cancer metastasis and drug resistance, providing potential therapeutic targets for these diseases.